Investor Insight With a sharp focus on discovery and resource growth, NevGold presents a compelling investment opportunity as an undervalued gold and critical metals...
RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated...
Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce the fourth and final closing of its non-brokered private placement offering...
The U.S. strikes on Iranian nuclear facilities Saturday have rendered ideal results for addressing the crisis between Iran and Israel, according to former President...